833-489-4968

Long COVID

  • Home
  • Atherosclerotic Cardiovascular Disease (ASCVD)

Understanding the Lingering Effects of COVID-19 and the Role of Clinical Research

What Is Long COVID?

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), refers to a range of symptoms that persist for weeks or even months after a person has recovered from the initial phase of COVID-19. While most people recover from COVID-19 within a few days to weeks, a significant portion continues to experience symptoms that interfere with daily life, sometimes long after the virus is no longer detectable in their body.

Long COVID can affect anyone — regardless of age, health status, or the severity of their initial illness. Even individuals who had mild or asymptomatic infections can develop long-term symptoms. Research is still ongoing, but current estimates suggest that around 10–30% of people infected with COVID-19 may experience long COVID.

Common Symptoms of Long COVID

Long COVID presents in a wide variety of symptoms that can affect nearly every system in the body. These symptoms may fluctuate, recur, or evolve over time.

Frequently Reported Long COVID Symptoms Include:

  • Chronic fatigue or exhaustion

  • Shortness of breath

  • Brain fog (difficulty concentrating or thinking clearly)

  • Memory issues

  • Sleep disturbances

  • Muscle and joint pain

  • Persistent cough

  • Chest pain or tightness

  • Headaches

  • Heart palpitations

  • Depression and anxiety

  • Loss of taste or smell

  • Dizziness or lightheadedness

  • Gastrointestinal issues

This condition can significantly impair quality of life, making it difficult for people to return to work, manage household responsibilities, or engage in physical activity. In some cases, long COVID symptoms mimic other chronic illnesses, making diagnosis and treatment more complicated.

Who Is at Risk of Developing Long COVID?

Long COVID can affect anyone, but research has identified certain groups who may be more likely to experience persistent symptoms:

  • People who experienced more severe initial COVID-19 illness

  • Women

  • Older adults

  • Individuals with pre-existing conditions such as diabetes, hypertension, or autoimmune diseases

  • Those who were hospitalized or required intensive care during COVID-19

  • Unvaccinated individuals

However, even young, previously healthy individuals can develop long COVID. The unpredictable nature of the condition underscores the importance of continued vigilance, vaccination, and follow-up care.

Diagnosis and Evaluation of Long COVID
 Because long COVID affects multiple organ systems and symptoms vary widely between individuals, diagnosis can be challenging. There is currently no single test for long COVID. Instead, healthcare providers rely on a combination of clinical evaluations, symptom history, and diagnostic tests to rule out other causes.

Typical Diagnostic Workup May Include:

  • Detailed medical history and symptom timeline

  • Blood tests to check for inflammation, organ function, or autoimmune activity

  • Imaging studies such as chest X-rays, CT scans, or MRIs

  • Pulmonary function tests for respiratory symptoms

  • Cognitive assessments for memory and concentration issues

  • Cardiovascular evaluations including ECG or echocardiograms

As long COVID is a relatively new condition, diagnostic guidelines are still evolving. Multidisciplinary care involving specialists such as pulmonologists, neurologists, cardiologists, and mental health professionals is often necessary.

Treatment Options for Long COVID

There is currently no universal treatment or cure for long COVID. Management focuses on relieving symptoms, improving function, and supporting mental and physical health.

Treatment Strategies Often Include:

  • Symptom-based care: Tailored to individual complaints (e.g., inhalers for breathing issues, medications for sleep or mood disturbances)

  • Physical therapy: For managing fatigue, joint pain, and mobility challenges

  • Occupational therapy: To help patients regain function and adapt to changes in energy or cognitive ability

  • Mental health support: Addressing anxiety, depression, or PTSD that may arise from long illness

  • Pacing and energy conservation: A technique often used to manage post-exertional malaise by helping patients balance activity and rest

  • Lifestyle changes: Nutrition, sleep hygiene, and stress management strategies

Because long COVID is still being researched, patients may need to try multiple treatment approaches and adjust plans based on evolving symptoms. Support groups and long COVID clinics have become valuable resources for those navigating recovery.

For most people, treatment is supportive: rest, hydration, and medications to manage symptoms. However, antivirals are an important option for those at higher risk of complications.

Supportive Treatment Includes:

  • Adequate hydration

     

  • Bed rest

     

  • Acetaminophen or ibuprofen for fever and aches

     

  • Avoiding physical exertion while symptomatic

     

Antiviral Medications:

  • Oseltamivir (Tamiflu): Oral capsule or liquid, most effective if started within 48 hours.

     

  • Zanamivir (Relenza): Inhaled powder, not suitable for individuals with respiratory conditions.

     

  • Peramivir (Rapivab): Intravenous option for hospitalized or high-risk patients.

     

  • Baloxavir Marboxil (Xofluza): A single-dose antiviral treatment, particularly effective against early-stage infection.

     

These medications work by blocking the virus’s ability to replicate, helping to reduce symptom duration and lower the risk of complications or transmission. Clinical trials are essential to evaluating and improving these treatments in diverse populations.

Prevention: Vaccination and Beyond
 Vaccination remains the most effective way to prevent influenza infection and its complications. Since influenza viruses constantly evolve, flu vaccines are updated annually to match the most likely circulating strains.

Preventive Strategies Include:

  • Annual Flu Vaccination: Recommended for all individuals over six months of age

     

  • Hand Hygiene: Frequent washing with soap or alcohol-based hand sanitizers

     

  • Cough and Sneeze Etiquette: Covering the mouth and nose with a tissue or elbow

     

  • Avoiding Contact with Sick Individuals: Especially important in high-risk environments

     

  • Wearing Masks and Social Distancing: Especially during outbreaks or pandemics

     

While flu vaccines are not 100% effective, they significantly reduce the risk of infection, hospitalization, and severe outcomes. Clinical trials help improve vaccine efficacy and develop better preventive tools — including nasal sprays, high-dose vaccines for older adults, and ultimately a universal flu vaccine.

The Role of Clinical Research in Long COVID

Research is critical in understanding the biology of long COVID, identifying effective treatments, and developing guidelines for care. Clinical trials are investigating how and why long COVID occurs, what makes certain people more vulnerable, and what therapies may help shorten recovery or reverse symptoms.

Key Research Areas Include:

  • Pathophysiology: Exploring how lingering viral particles, inflammation, immune system responses, or microclots might contribute to long COVID

  • Risk Factors: Identifying genetic, demographic, or health-related factors that increase vulnerability

  • Biomarkers: Finding measurable signs in blood or tissues that can confirm or predict long COVID

  • Treatment Trials: Testing medications, supplements, physical therapy regimens, and rehabilitation techniques

  • Impact on Children: Studying the effects of long COVID in pediatric populations

  • Mental Health Correlation: Understanding how long COVID affects emotional well-being and vice versa

By participating in clinical research, patients and healthcare professionals can help accelerate the development of treatments and provide evidence-based care options for future patients.

Miami: A Center for Long COVID Research

Given its diverse population and high rate of COVID-19 cases, Miami has become a hub for long COVID studies. Clinical trials conducted in this region offer critical insights into how long COVID affects different racial, ethnic, and socioeconomic groups.

At BioResearch Partner, we support long COVID clinical studies by assisting sponsors and investigators in site selection, patient recruitment, regulatory compliance, and data integrity. Our mission is to connect communities to high-quality research that leads to better care and more informed public health decisions.

How BioResearch Partner Supports Long COVID Research
 As a full-service clinical trial partner, we help advance long COVID studies in several ways:

  • Coordinating multi-specialty trials across respiratory, neurological, and cardiovascular domains

  • Recruiting diverse patient populations for inclusive, generalizable results

  • Ensuring timely regulatory approvals and patient safety monitoring

  • Supporting community education and outreach to raise awareness of long COVID

  • Delivering high-quality data to sponsors, regulators, and clinicians

Whether you’re a trial sponsor or a patient interested in participating in research, BioResearch Partner ensures your study or experience is handled with care, integrity, and purpose.

Join the Effort to Understand and Defeat Long COVID

The long-term effects of COVID-19 continue to affect millions. But through research, collaboration, and community engagement, we can develop better solutions to treat and prevent this condition.

If you’re experiencing lingering symptoms after COVID-19 or are interested in sponsoring or participating in long COVID studies, reach out to us.

📞 Call: 833-489-4978
 🌐 Visit: www.bioresearchpartner.com
 📩 Email: info@bioresearchpartner.com

Become a BioResearch Partner

Together, we can unlock the mysteries of long COVID and work toward a future where recovery is complete, and lasting health is within reach.

Call Us Now